CastelnovoC., LunghiG., De VecchiA.Comparison of three different tests for assessment of hepatitis C virus in dialysis patients.Perit Dial Int1995; 15: 241–5.
2.
BrillantiS., MasciC., RicciP.Significance of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C.Hepatology1992; 15: 998–1001.
3.
QirogaJ.A., CampilloM.L., CatilloI.IgM antibody to hepatitis C virus in acute and chronic hepatitis C.Hepatology1991; 14: 38–43.
4.
SansonnoD., DammaccoF.Antibodies to hepatitis C virus in non-A non-B post transfusional hepatitis.Lancet1989; 2: 798–9.
5.
TassopoulosN.C., HatzakisH., LennartzL.Early prediction of successful alpha interpheron therapy of chronic hepatitis C bycore-IgM antibodies to hepatitis C virus.J Hepatol1994; 20: 235–6.
6.
FabriziF., LunghiG., GuarnoriI.IgM antibodies response to hepatitis C virus in end stage renal disease.Nephrol Dial Transplant1996; 11: 314–18.
7.
OlivaJ.A., ErcillaG., MallafreJ.M.Markers of hepatitis C infection among hemodialysis patients with acute and chronic infection: implications for infection control strategies in hemodialysis units.Int J ArtifOrgans1995; 18: 73–8.
8.
NavarroJ.F., TeruelJ., MateosM.IgM antibodies to hepatitis C virus and hemodialysis patients (Letter).Nephrol Dial Transplant1994; 9: 1210–11.
9.
LauJ.Y.N., DavisG.L., KnifferJ.Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.Lancet1993; 341: 1501–4.
10.
SijogrenM., HoofnagleJ.H.Immunoglobulin Mantibodies to hepatitis B core antigen in patients with chronic type B hepatitis.Gastroenterology1995; 89: 252–8.
